Blinatumomab User Reviews & Ratings
Brand names: Blincyto
Blinatumomab has an average rating of 10.0 out of 10 from a total of 2 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Acute Lymphoblastic Leukemia | 2 reviews for Acute Lymphoblastic Leukemia | 29 medications |
- ble...
- Taken for 6 months to 1 year
- September 27, 2023
Blinatumomab for Acute Lymphoblastic Leukemia "I have had great results from having Blincyto treatments. I have never experienced any side effects so far."
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about blinatumomab
- Check interactions
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: bispecific T-cell engagers (BiTE)
- Breastfeeding
- En español
For Acute Lymphoblastic Leukemia "Brought 11-year-old daughter into remission of acute lymphoblastic leukemia. Received a total of 6 rounds of Blina. Due to extreme sensitivity and several complications from traditional chemo drugs. Still in remission and in maintenance therapy. She tolerated it well. She experienced headaches and lethargy the first week, but the remaining 28 days were okay."